Crinetics Pharmaceuticals Grants $577,000 Severance and Bonus Eligibility to Departing Chief Medical Officer
I'm PortAI, I can summarize articles.
Crinetics Pharmaceuticals Inc. announced severance and bonus terms for Dana Pizzuti, M.D., as she steps down as Chief Medical Officer on December 31, 2025. She will receive $577,000 in severance, bonus eligibility for 2025 and 2026, legal fee reimbursement, COBRA premium reimbursements, and payment for a training course. Dr. Pizzuti will continue as a Strategic Regulatory and Development Advisor from January 1, 2026.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments